Vital

When the medication isn't working

GLP-1 Stopped Working? Plateau, Maintenance, or Tolerance

When a GLP-1 stopped working after months of steady loss, the cause is usually a plateau or the start of maintenance, not tolerance. Here is how to tell the difference and what to discuss with your prescriber.

Last reviewed

The Vital angle

Vital keeps a full dose history with the amount, strength, source type, and date of each dose, so missed weeks and product changes are easy to spot. Weight and body trends from Apple Health sit next to that history, which helps you and your prescriber tell a plateau from maintenance.

It is a common story: the first six to nine months on a GLP-1 go well, then the scale stops moving, hunger feels louder, and it seems the GLP-1 stopped working. Many people assume their body built a tolerance. The trial data point to a different explanation in most cases. This guide explains what usually happens after the first months, what to rule out, and what to bring to your prescriber.

It applies to semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®). It is general information, not medical advice.

Every trial curve flattens

In STEP 1, average weight loss on semaglutide 2.4 mg slowed and then levelled off around week 60 to 68. In SURMOUNT-1, weight loss on tirzepatide followed the same shape, with the curve flattening toward week 72. Nobody in these trials kept losing at the same rate forever.

The reason is energy balance, not a drug failure. As you lose weight, your body needs fewer calories. Your metabolism also adapts, and you tend to move a little less without noticing. At some point, the intake that the medication supports matches what your smaller body burns, and weight holds steady. That is the expected end point of weight loss on any treatment. Weight loss plateaus covers the details.

Tolerance is not the usual explanation

If the medication truly stopped acting, stopping it would make no difference. The trials that tested this found the opposite.

  • In STEP 4, people who reached semaglutide 2.4 mg were then split into two groups. Those who kept taking it lost a further 7.9 percent on average over 48 weeks. Those switched to placebo regained 6.9 percent.
  • In SURMOUNT-4, people who lost about 20 percent on tirzepatide were split the same way. Those who continued lost a further 5.5 percent over 52 weeks. Those switched to placebo regained 14 percent.
  • In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they lost within a year.

So when weight is stable on a GLP-1, the medication is often still doing a lot of work. It is holding the new weight in place. That is what maintenance looks like.

Appetite effects can feel weaker over time, and some studies report that differences in hunger ratings fade in later months. That is not the same as the drug stopping. Your baseline has changed: you are comparing month ten to month one, when the effect was new and strong.

Rule out practical causes first

Before you put a stall down to biology, check the simple things. A change in any of these can look like a medication that stopped working:

  1. Missed or late doses. Even a few delayed weeks lower the steady level of medicine in your body. See missed GLP-1 dose.
  2. A new product or pharmacy. A switch from brand to compounded, a new compounded concentration, or a new batch can change the dose you actually get. See compounded vs brand semaglutide.
  3. Storage. A pen or vial that got hot, froze, or passed its room-temperature limit may be less effective. See GLP-1 left out of the fridge.
  4. A shortage swap. If you had to take a lower dose for a while, your appetite may have reset. See GLP-1 shortage.
  5. Injection problems. Pens that do not fully deliver, or leaks at the site, mean partial doses. See injection technique.
  6. New medicines. Steroids, some antidepressants, and some other drugs can raise appetite or weight.

Habit drift after the first months

In the first months, most people eat very little without trying. Later, appetite returns partway, portions creep up, and social meals come back. None of this is a failure, but it does change the math. A two-week stretch of honest food logging often shows where the gap came from.

Protein and resistance training matter more in this phase, because they protect muscle and help keep your metabolism higher. See protein on GLP-1. If hunger seems worse late in your dose week, read food noise coming back on a GLP-1.

Measure more than the scale

Weight is only one signal, and it is a noisy one. During a stall, other measures often keep changing. If you lift weights and eat enough protein, you can lose fat and keep or gain muscle while the scale holds still.

Useful things to record for a month:

  • Your weekly average weight, not daily readings.
  • Waist measurement, taken at the same spot each time.
  • How hungry you are on each day of the dose week.
  • Each dose, its date, and any change of product or pharmacy.

If the waist keeps shrinking while weight holds, the medication and your habits are still having an effect.

When it might be a true plateau or non-response

There are three different situations, and each needs a different conversation:

  • Stable weight after good loss. You lost a meaningful amount and have held it for months. This is often successful maintenance.
  • A stall well short of your goal. You lost some weight, then stopped long before your prescriber expected. There may be room to adjust the plan.
  • Little loss from the start. You never lost much, even at a full dose for several months. Some people respond less to a given medication.

Tracking four-week averages, not single weigh-ins, makes it easier to see which one applies to you.

What to discuss with your prescriber

Bring your dose history, any missed weeks, product changes, and your weight trend over at least three months. Questions that help:

  1. Is my current weight a plateau, or have I reached a maintenance point?
  2. Am I at my maximum tolerated dose, or is there room to increase?
  3. Could another condition, such as thyroid problems or perimenopause, be part of this?
  4. Could a medicine I take be affecting my weight or appetite?
  5. If the medication is no longer the right fit, what are the options, such as switching from semaglutide to tirzepatide?
  6. What is the plan for long-term maintenance?

Do not stop the medication, take extra doses, or change your schedule on your own. The trials above show that stopping often leads to regain, and dose changes need a prescriber.

When to get care now

Get medical help right away for:

  • Severe stomach pain that does not go away, sometimes spreading to your back, with or without vomiting.
  • Vomiting or diarrhea that stops you from keeping fluids down.
  • Pain in the upper right stomach, fever, or yellow skin or eyes.
  • Swelling of the face, lips, or throat, or trouble breathing.
  • A lump in the neck, trouble swallowing, or hoarseness that does not go away.

Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Assuming tolerance without checking

    In STEP 4 and SURMOUNT-4, people who kept taking the medication held or lost more weight, while people switched to placebo regained. Stable weight on treatment often means the drug is still working.

  • Stopping the medication to reset it

    The STEP 1 extension found that people regained about two-thirds of their lost weight within a year of stopping semaglutide. Any change to treatment belongs with your prescriber.

  • A quiet change of product or pharmacy

    A new compounded concentration, batch, or source can change the dose you actually receive. Record the product details each time you refill.

  • Missed or late doses adding up

    Several late weeks lower the steady level of medicine in your body and can make appetite return. A dose history shows the gaps.

  • Judging by the scale alone

    Daily weight moves with water and salt. Waist size, weekly averages, and body composition can keep improving during a stall.

Frequently asked questions

  • Tolerance is not the usual explanation. In STEP 4 and SURMOUNT-4, people who stayed on the medication kept their weight off or lost more, while those switched to placebo regained. Weight loss slows because your body needs fewer calories at a lower weight.

  • The most common reasons are a normal plateau, habit drift, missed doses, or a change in product or storage. Trial weight loss curves flatten after about a year. Your prescriber can help find the cause.

  • Yes. In the main trials, average weight loss slowed and then levelled off after about 60 to 72 weeks. A long stall well short of your goal is still worth discussing with your prescriber.

  • Trials show that most people regain weight after stopping. In the STEP 1 extension, people regained about two-thirds of their lost weight within a year. Talk to your prescriber before any change.

  • Track your weekly average weight and waist size for at least a month. Holding a meaningful loss for months is often maintenance. A stall far from your goal is a plateau to review with your prescriber.

Sources

  1. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4) · JAMA
  2. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4) · JAMA
  3. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension · NIH / NCBI
  4. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine
  5. The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity · NIH / NCBI

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.